{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:36:48Z","timestamp":1768685808307,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T00:00:00Z","timestamp":1458604800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"crossref","award":["11-117436"],"award-info":[{"award-number":["11-117436"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s40268-016-0129-9","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T15:04:05Z","timestamp":1458659045000},"page":"173-180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Population Pharmacokinetic Modelling of FE 999049, a Recombinant Human Follicle-Stimulating Hormone, in Healthy Women After Single Ascending Doses"],"prefix":"10.1007","volume":"16","author":[{"given":"Trine H\u00f8yer","family":"Rose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"R\u00f6shammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Erichsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Grundemar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnny T.","family":"Ottesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,22]]},"reference":[{"key":"129_CR1","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/humrep\/dei042","volume":"20","author":"R Homburg","year":"2005","unstructured":"Homburg R. Clomiphene citrate\u2014end of an era? A mini-review. Hum Reprod. 2005;20:2043\u201351.","journal-title":"Hum Reprod"},{"key":"129_CR2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1210\/er.2005-0015","volume":"27","author":"NS Macklon","year":"2006","unstructured":"Macklon NS, Stouffer RL, Giudice LC, Fauser BC. The science behind 25\u00a0years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006;27:170\u2013207.","journal-title":"Endocr Rev"},{"key":"129_CR3","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1016\/S0021-9258(18)83656-0","volume":"264","author":"JL Keene","year":"1989","unstructured":"Keene JL, Matzuk MM, Otani T, Fauser BC, Galway AB, Hsueh AJ, et al. Expression of biologically active human follitropin in Chinese hamster ovary cells. J Biol Chem. 1989;264:4769\u201375.","journal-title":"J Biol Chem"},{"key":"129_CR4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/humupd\/2.2.172","volume":"2","author":"CM Howles","year":"1996","unstructured":"Howles CM. Genetic engineering of human FSH (Gonal-F). Hum Reprod Update. 1996;2:172\u201391.","journal-title":"Hum Reprod Update"},{"key":"129_CR5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/molehr\/2.5.371","volume":"2","author":"W Olijve","year":"1996","unstructured":"Olijve W, de Boer W, Mulders JW, van Wezenbeek PM. Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon). Mol Hum Reprod. 1996;2:371\u201382.","journal-title":"Mol Hum Reprod"},{"key":"129_CR6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humupd\/dmn065","volume":"15","author":"BCJM Fauser","year":"2009","unstructured":"Fauser BCJM, Mannaerts BMJL, Devroey P, Leader A, Boime I, Baird DT. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency. Hum Reprod Update. 2009;15:309\u201321.","journal-title":"Hum Reprod Update"},{"key":"129_CR7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/jcph.328","volume":"54","author":"H Olsson","year":"2014","unstructured":"Olsson H, Sandstr\u00f6m R, Grundemar L. Different pharmacokinetic and pharmacodynamic properties of recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non-human cell line. J Clin Pharmacol. 2014;54:1299\u2013307.","journal-title":"J Clin Pharmacol"},{"key":"129_CR8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s40261-015-0276-8","volume":"35","author":"H Olsson","year":"2015","unstructured":"Olsson H, Sandstr\u00f6m R, Bagger Y. Dose-exposure proportionality of a novel recombinant follicle-stimulating hormone (rFSH), FE 999049, derived from a human cell line, with comparison between Caucasian and Japanese women after subcutaneous administration. Clin Drug Investig. 2015;35:247\u201353.","journal-title":"Clin Drug Investig"},{"key":"129_CR9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10928-008-9094-4","volume":"35","author":"JE Ahn","year":"2008","unstructured":"Ahn JE, Karlsson MO, Dunne A, Ludden TM. Likelihood based approaches to handling data below the quantification limit using NONMEM VI. J Pharmacokinet Pharmacodyn. 2008;35:401\u201321.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"129_CR10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1012299115260","volume":"28","author":"S Beal","year":"2001","unstructured":"Beal S. Ways to fit a PK model with some data below the quantification limit. J Pharmacokinet Pharmacodyn. 2001;28:481\u2013504.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"129_CR11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1208\/s12248-009-9112-5","volume":"11","author":"M Bergstrand","year":"2009","unstructured":"Bergstrand M, Karlsson MO. Handling data below the limit of quantification in mixed effect models. AAPS J. 2009;11:371\u201380.","journal-title":"AAPS J"},{"key":"129_CR12","unstructured":"Beal S, Sheiner LB, Boeckmann A, Bauer RJ. NONMEM user\u2019s guides. (1989\u20132011). Ellicott City: Icon Development Solutions; 2011."},{"key":"129_CR13","unstructured":"R Development Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2010."},{"key":"129_CR14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","volume":"79","author":"L Lindbom","year":"2005","unstructured":"Lindbom L, Pihlgren P, Jonsson EN. PsN-Toolkit\u2014a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed. 2005;79:241\u201357.","journal-title":"Comput Methods Programs Biomed"},{"key":"129_CR15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cmpb.2003.11.003","volume":"75","author":"L Lindbom","year":"2004","unstructured":"Lindbom L, Ribbing J, Jonsson EN. Perl-speaks-NONMEM (PsN)\u2014a Perl module for NONMEM related programming. Comput Methods Programs Biomed. 2004;75:85\u201394.","journal-title":"Comput Methods Programs Biomed"},{"key":"129_CR16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","volume":"58","author":"EN Jonsson","year":"1999","unstructured":"Jonsson EN, Karlsson MO. Xpose\u2014an s-plus based population pharmacokinetic\/pharmacodynamic model building aid for nonmem. Comput Methods Programs Biomed. 1999;58:51\u201364.","journal-title":"Comput Methods Programs Biomed"},{"key":"129_CR17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/clpt.2010.54","volume":"88","author":"R Greef de","year":"2010","unstructured":"de Greef R, Zandvliet AS, de Haan AF, Ijzerman-Boon PC, Marintcheva-Petrova M, Mannaerts BM. Dose selection of corifollitropin alfa by modeling and simulation in controlled ovarian stimulation. Clin Pharmacol Ther. 2010;88:79\u201387.","journal-title":"Clin Pharmacol Ther"},{"key":"129_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2125.1998.00644.x","volume":"45","author":"MO Karlsson","year":"1998","unstructured":"Karlsson MO, Wade JR, Loumaye E, Munafo A. The population pharmacokinetics of recombinant- and urinary-human follicle stimulating hormone in women. Br J Clin Pharmacol. 1998;45:13\u201320.","journal-title":"Br J Clin Pharmacol"},{"key":"129_CR19","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/oxfordjournals.humrep.a137899","volume":"8","author":"JY Cotonnec le","year":"1993","unstructured":"le Cotonnec JY, Porchet HC, Beltrami V, Howles C. Comparative pharmacokinetics of two urinary human follicle stimulating hormone preparations in healthy female and male volunteers. Hum Reprod. 1993;8:1604\u201311.","journal-title":"Hum Reprod"},{"key":"129_CR20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0015-0282(16)56645-X","volume":"61","author":"JY Cotonnec le","year":"1994","unstructured":"le Cotonnec JY, Porchet HC, Beltrami V, Khan A, Toon S, Rowland M. Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady state pharmacokinetics. Fertil Steril. 1994;61:679\u201386.","journal-title":"Fertil Steril"},{"key":"129_CR21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0015-0282(97)00503-7","volume":"69","author":"J-Y Cotonnec le","year":"1998","unstructured":"le Cotonnec J-Y, Loumaye E, Porchet HC, Beltrami V, Munafo A. Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone. Fertil Steril. 1998;69:201\u20139.","journal-title":"Fertil Steril"},{"key":"129_CR22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/(SICI)1520-6017(200003)89:3<297::AID-JPS2>3.0.CO;2-P","volume":"89","author":"CJH Porter","year":"2000","unstructured":"Porter CJH, Charman SA. Lymphatic transport of proteins after subcutaneous administration. J Pharm Sci. 2000;89:297\u2013310.","journal-title":"J Pharm Sci"},{"key":"129_CR23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0015-0282(16)55624-6","volume":"59","author":"B Mannaerts","year":"1993","unstructured":"Mannaerts B, Shoham Z, Schoot D, Bouchard P, Harlin J, Fauser B, et al. Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489*) in gonadotropin-deficient volunteers. Fertil Steril. 1993;59:108\u201314.","journal-title":"Fertil Steril"},{"key":"129_CR24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/humupd\/2.2.153","volume":"2","author":"BM Mannaerts","year":"1996","unstructured":"Mannaerts BM, Rombout F, Out HJ, Coelingh BH. Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy. Hum Reprod Update. 1996;2:153\u201361.","journal-title":"Hum Reprod Update"},{"key":"129_CR25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.rbmo.2011.04.002","volume":"23","author":"WL Ledger","year":"2011","unstructured":"Ledger WL, Fauser BCJM, Devroey P, Zandvliet AS, Mannaerts BMJL. Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response. Reprod BioMed Online. 2011;23:150\u20139.","journal-title":"Reprod BioMed Online"}],"container-title":["Drugs in R&amp;D"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-016-0129-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40268-016-0129-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-016-0129-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T23:26:17Z","timestamp":1655335577000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40268-016-0129-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,22]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["129"],"URL":"https:\/\/doi.org\/10.1007\/s40268-016-0129-9","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,22]]}}}